FITY (Fifty 1 Labs) EV-to-EBIT: -847.00 (As of Jul. 09, 2026)


What is Fifty 1 Labs EV-to-EBIT?

Fifty 1 Labs FITY EV-to-EBIT is -847.00 as of Jul. 09, 2026.

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Fifty 1 Labs's Enterprise Value is $0.85 Mil. Fifty 1 Labs's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.00 Mil. Therefore, Fifty 1 Labs's EV-to-EBIT for today is -847.00.

The historical rank and industry rank for Fifty 1 Labs's EV-to-EBIT or its related term are showing as below:

FITY' s EV-to-EBIT Range Over the Past 10 Years
Min: -847   Med: 0   Max: 0
Current: -847

FITY's EV-to-EBIT is not ranked
in the Drug Manufacturers industry.
Industry Median: 15.91 vs FITY: -847.00

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Fifty 1 Labs's Enterprise Value for the quarter that ended in Jun. 2024 was $13.04 Mil. Fifty 1 Labs's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.00 Mil. Fifty 1 Labs's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 was -0.01%.


Fifty 1 Labs  (OTCPK:FITY) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Fifty 1 Labs's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2024 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2024 ) =EBIT / Enterprise Value (Q: Jun. 2024 )
=-0.001/13.035643
=-0.01 %

Fifty 1 Labs's Enterprise Value for the quarter that ended in Jun. 2024 was $13.04 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Fifty 1 Labs's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Fifty 1 Labs EV-to-EBIT Related Terms


Fifty 1 Labs EV-to-EBIT Historical Data

* Premium members only.

The historical data trend for Fifty 1 Labs's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fifty 1 Labs EV-to-EBIT Chart

Fifty 1 Labs Annual Data
Trend Dec04 Jun06 Jun07 Jun08 Jun09 Jun10 Jun21 Jun22 Jun23 Jun24
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only Premium Member Only -9.63 0.00 -80.45 -13.98 -13,035.64

Fifty 1 Labs Semi-Annual Data
Dec03 Dec04 Jun06 Jun07 Jun08 Jun09 Jun10 Jun21 Jun22 Jun23 Jun24
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -9.63 0.00 -80.45 -13.98 -13,035.64

FITY vs GRPS, KOAN, PTPI: EV-to-EBIT Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Fifty 1 Labs's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fifty 1 Labs EV-to-EBIT vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Fifty 1 Labs's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Fifty 1 Labs's EV-to-EBIT falls into.



Fifty 1 Labs EV-to-EBIT Calculation

Fifty 1 Labs's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=0.847/-0.001
=-847.00

Fifty 1 Labs's current Enterprise Value is $0.85 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Fifty 1 Labs's EBIT for the trailing twelve months (TTM) ended in Jun. 2024 was $-0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EV-to-EBIT →
What does a EV-to-EBIT of -847.00 mean?
Fifty 1 Labs (FITY) has a EV-to-EBIT of -847.00 as of Jul. 09, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Fifty 1 Labs and its competitors.
Is Fifty 1 Labs' EV-to-EBIT too high?
Fifty 1 Labs' current EV-to-EBIT is -847.00.
How does Fifty 1 Labs' EV-to-EBIT compare to GRPS and KOAN?
Fifty 1 Labs' EV-to-EBIT of -847.00 can be compared against companies in the Drug Manufacturers industry. The industry median EV-to-EBIT is 15.91. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Drug Manufacturers company?
The median EV-to-EBIT among Drug Manufacturers companies is 15.91, based on 690 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Fifty 1 Labs and its competitors. For the Drug Manufacturers industry, the median EV-to-EBIT is 15.91 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fifty 1 Labs's current EV-to-EBIT is -847.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fifty 1 Labs stock overvalued right now?
Fifty 1 Labs (FITY) has a current EV-to-EBIT of -847.00. The current EV-to-EBIT is -847.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Fifty 1 Labs (FITY), the current EV-to-EBIT is -847.00 as of Jul. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Fifty 1 Labs Business Description

Address 1505 West 2nd Avenue, Suite 506, Melbourne, FL, USA, V6J 1H2
Fifty 1 Labs Inc is a holding company with subsidiaries that operate in the sports supplement, fitness equipment, and health and wellness industries, respectively. The company offers a line of supplements - including pre-workout formulas, BCAAs, ION+ Electrolyte Formula, Turmeric Gummies, and Ashwagandha Gummies - designed to enhance athletic performance, recovery, and overall health.